TARSUS PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 55893000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fc7d79f3-ca16-418a-a40d-5c40c12af880
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-21-000020Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/cash-and-equivalents/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fc7d79f3-ca16-418a-a40d-5c40c12af880
History
- no predecessors — first report